Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 1, 2004
Preliminary worldwide sales of TAXUS systems for the month of August were approximately $200 million.
-
Aug 31, 2004
Registry designed to assess physician usage patterns and evaluate outcome data in "real world" patients.
-
Aug 26, 2004
ATLAS clinical trial is the first trial using Boston Scientific's new Liberté™ coronary stent as a platform for its paclitaxel-eluting coronary stent system.
-
Aug 25, 2004
A live webcast and replay of the September 1 conference call will be available.
-
Aug 25, 2004
Company will launch the device immediately
-
Aug 23, 2004
Company plans to launch the product in the United States immediately.
-
Aug 19, 2004
Extended expiration date applies to all sizes of the TAXUS system for sale in the United States.
-
Aug 10, 2004
Seattle device company is developing a neurostimulation system whose initial application focused on treating stroke patients.
-
Jul 26, 2004
"We experienced impressive growth across all our businesses and regions," said Jim Tobin, President and Chief Executive Officer.
-
Jul 22, 2004
ATLAS is the first clinical trial using Boston Scientific's new Liberté coronary stent as a platform for its paclitaxel-eluting coronary stent system.